JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A5065 Bicalutamide
1 Citation

Target: Androgen Receptors

Summary: Androgen receptor antagonist

≥42.89 mg/mL
A1389 WZ4002

Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent

≥24.7 mg/mL
A1670 Enzastaurin (LY317615)
2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
A5096 PF-04217903

Target: c-MET

Summary: C-Met inhibitor,selective and ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
A2782 Amonafide

Summary: DNA intercalator,Topo II inhibitor

insoluble in EtOH; insoluble in H2O; ≥14.17 mg/mL
A1659 Dutasteride

Target: 5-alpha Reductases

Summary: 5-alpha-reductase inhibitor

≥26.43 mg/mL
A2451 Epirubicin HCl

Target: Topoisomerases

Summary: Antibiotic antitumor agent

≥29.00 mg/mL
A1196 SGX-523
1 Citation

Target: MET

Summary: MET inibitor, highly selective, ATP-competitive

≥17.95 mg/mL
A5112 XL147

Target: PI3K

Summary: PI3K inhibitor,selective and reversible

≥22.45 mg/mL
A2681 TGX-221

Target: PI3K

Summary: PI3Kβ inhibitor,potent,selective and ATP competitive

insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL